Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
Not yet recruiting · NCT07434180 · Registry updated 2026-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary | Cancer of Unknown Primary | Not yet recruiting | Phase 2 | 2026-02-25 | NCT07434180 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Health and Medical Research Council, Australia | 27 |
| Novartis | 114 |
| Peter MacCallum Cancer Centre, Australia | 48 |
| SOFIE | 5 |
| University of Melbourne | 71 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |